<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A retrospective survey of the case records of 130 patients with newly diagnosed non-<z:hpo ids='HP_0100651'>insulin-dependent diabetes mellitus</z:hpo> (<z:mp ids='MP_0002057'>NIDDM</z:mp>) was performed to assess the effect of 1 year of clinical attendance on blood <z:chebi fb="105" ids="17234">glucose</z:chebi> control, body weight, <z:chebi fb="23" ids="18059">lipid</z:chebi> profile and blood pressure </plain></SENT>
<SENT sid="1" pm="."><plain>The mean age of these patients was 63 +/- (SE) 0.1 years and 45% were 65 years or older </plain></SENT>
<SENT sid="2" pm="."><plain>Body mass index (BMI) was 28.3 +/- 0.49 kg m-2 and 72% were overweight or <z:mp ids='MP_0001261'>obese</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Sixty-seven percent of the patients were hypertensive (WHO criteria) </plain></SENT>
<SENT sid="4" pm="."><plain>Serum cholesterol was 6.0 +/- 0.2 mmol/l, <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> 1.0 +/- 0.0 mmol/l and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> 3.14 +/- 0.29 mmol/l (non-fasting) </plain></SENT>
<SENT sid="5" pm="."><plain>Seventy-two percent of the patients were managed on diet alone and 23% by diet plus sulphonylurea </plain></SENT>
<SENT sid="6" pm="."><plain>The remaining 5% were treated by <z:chebi fb="0" ids="6801">metformin</z:chebi> or a combination of <z:chebi fb="0" ids="6801">metformin</z:chebi> plus sulphonylurea </plain></SENT>
<SENT sid="7" pm="."><plain>After one year, glycated <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> (HbA1) decreased from 10.7 +/- 0.3% to 8.2 +/- 0.2% (P less than 0.01; <z:mpath ids='MPATH_458'>normal</z:mpath> less than 7.5%) </plain></SENT>
<SENT sid="8" pm="."><plain>The sulphonylurea groups showed similar decreases in HbA1 </plain></SENT>
<SENT sid="9" pm="."><plain>Overall there was a small but significant fall in BMI (-0.5 +/- 0.2 kg m-2; P less than 0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>However, the diet treated patients showed a significant decrease in BMI (-0.8 +/- 0.3 kg m-2; P less than 0.01) whilst BMI increased in the sulphonylurea treated group (+0.7 +/- 0.2 kg m-2; P less than 0.01) </plain></SENT>
<SENT sid="11" pm="."><plain>Serum <z:chebi fb="23" ids="18059">lipid</z:chebi> concentrations remained unchanged in both groups </plain></SENT>
<SENT sid="12" pm="."><plain>The proportion of patients with <z:hpo ids='HP_0000822'>hypertension</z:hpo> remained the same </plain></SENT>
<SENT sid="13" pm="."><plain>Hence after one year of clinical attendance, HbA1 improved but there was minimal change in the associated <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e>.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>